Becton, Dickinson and Company

(New York Stock Exchange)
Back to all articles
Somewhat Bullish +42

BD’s (NYSE:BDX) Q1 CY2026 Sales Beat Estimates

AI-generated analysis

📈 BD reported Q1 CY2026 sales of $4.71 billion, surpassing analyst estimates of $4.68 billion by 0.8%.

📊 Revenue grew 5.2% year-on-year, beating the company's previous growth rates and Wall Street expectations.

💰 Non-GAAP profit came in at $2.90 per share, a 4.5% beat against consensus estimates of $2.77.

⚠️ Adjusted EBITDA missed analysts' significantly by 60%, reporting $522 million versus an expected $1.3 billion.

📉 Operating margin contracted sharply to 2% in the quarter, down from 8.5% in the same period last year.

💵 Free cash flow margin improved to 11.6%, a significant recovery from just 0.8% in the prior-year quarter.

🌍 Constant currency revenue growth slowed to 2.6% year-on-year compared to 6% the previous year.

🗣️ CEO Tom Polen highlighted that margins and EPS were ahead of expectations, attributing success to solid execution.

🏥 The company maintains a long history since 1897 with operations in virtually every hospital globally.

📉 Long-term demand appears suppressed as total sales over the trailing 12 months lag behind five-year highs.

💵 Constant currency revenue analysis indicates foreign exchange rates, not organic demand, are acting as a headwind.

🔮 Wall Street expects revenue to grow only 2.5% over the next 12 months, which is below sector averages.

⚖️ Over the last five years, BD's adjusted operating margin declined by 4.3 percentage points due to rising expenses.

📉 Full-year EPS guidance was raised slightly to a midpoint of $12.62 following the quarter results.

📈 Stock price jumped 2.5% to close at $148.32 immediately after earnings were released.

Bullish Signals
  • BD's Q1 CY2026 revenue beat analyst estimates by $30 million, with sales rising 5.2% year-over-year to $4.71 billion.
  • The company delivered a non-GAAP profit of $2.90 per share, which was 4.5% above Wall Street consensus estimates.
  • Management raised its full-year Adjusted EPS guidance midpoint to $12.62, signaling confidence in future performance.
  • Free Cash Flow Margin improved significantly to 11.6%, up from just 0.8% in the same quarter last year.
  • Constant currency revenue growth of 2.6% indicates underlying demand remains resilient despite foreign exchange headwinds.
Risk Factors
  • Adjusted EBITDA significantly missed analyst estimates by 60%, reporting $522 million against an expected $1.3 billion, indicating a major shortfall in earnings before interest, taxes, and debt expenses.
  • Operating margins collapsed to 2% from 8.5% in the same quarter last year, representing a severe 6.5 percentage point contraction that signals deteriorating cost efficiency.
  • Over the last two years, constant currency sales averaged only 5.6% growth, suggesting foreign exchange rates have been a major headwind masking underlying demand issues as domestic revenue declined by 2% annually during that period.
  • The company's adjusted operating margin decreased by 1.4 percentage points over the last five years, with a sharper 4.3 percentage point drop on a two-year basis, indicating rising expenses that management cannot pass on to customers.
  • Despite reporting revenue growth of 5.2% in Q1, Wall Street analysts project revenue will shrink by 2.4% over the next 12 months due to anticipated declines from 'below-the-line' items such as taxes.
  • The outlook implies BD is unable to sustain profitability growth even as top-line performance improves, with full-year EPS expected to decline while operating margins are anticipated to increase.
  • Total sales for the trailing 12 months reached $18.93 billion, which is close to revenue levels from five years ago, highlighting an inability to drive sustained long-term demand growth.
Full Analysis
Becton, Dickinson and Company (NYSE:BDX) reported first quarter fiscal year 2026 results that exceeded analyst expectations on both revenue and earnings per share. Revenue reached $4.71 billion, a 5.2% increase from the prior year period, surpassing the consensus estimate of $4.68 billion by $30 million or 0.8%. Non-GAAP profit per share came in at $2.90, marking a 4.5% beat against the projected $2.77, with the company also raising its full-year adjusted EPS guidance to a midpoint of $12.62. Despite the top-line beat, operational efficiency metrics showed significant weakness compared to historical norms and recent quarters. The reported operating margin for the quarter contracted sharply to 2%, down from 8.5% in the same quarter a year ago and representing a substantial miss against adjusted EBITDA estimates of $1.3 billion versus actuals of $522 million. Free cash flow margin, however, improved notably to 11.6% from just 0.8% in the prior year quarter. Management attributed some revenue headwinds previously to foreign exchange rates, noting that constant currency growth averaged 5.6% over the last two years compared to nominal declines, though full-year revenue projections by Wall Street analysts remain modest at 2.5%. The analysis highlights a divergence between current earnings beats and long-term business quality concerns due to declining operating margins and flat EPS growth over the past five years. While the stock rose 2.5% in intraday trading following the announcement, the article questions the sustainability of current performance, pointing to rising expenses that management has been unable to pass on to customers, which eroded profitability from a historical average of roughly 22% operating margin.